4NBI
 
 | | D-aminoacyl-tRNA deacylase (DTD) from Plasmodium falciparum in complex with D-tyrosyl-3'-aminoadenosine at 1.86 Angstrom resolution | | Descriptor: | 3'-deoxy-3'-(D-tyrosylamino)adenosine, D-tyrosyl-tRNA(Tyr) deacylase, TRIETHYLENE GLYCOL | | Authors: | Ahmad, S, Routh, S.B, Kamarthapu, V, Sankaranarayanan, R. | | Deposit date: | 2013-10-23 | | Release date: | 2013-12-18 | | Last modified: | 2023-11-08 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | Mechanism of chiral proofreading during translation of the genetic code.
Elife, 2, 2013
|
|
4NBJ
 | | D-aminoacyl-tRNA deacylase (DTD) from Plasmodium falciparum in complex with D-tyrosyl-3'-aminoadenosine at 2.20 Angstrom resolution | | Descriptor: | 3'-deoxy-3'-(D-tyrosylamino)adenosine, D-tyrosyl-tRNA(Tyr) deacylase | | Authors: | Ahmad, S, Routh, S.B, Kamarthapu, V, Sankaranarayanan, R. | | Deposit date: | 2013-10-23 | | Release date: | 2013-12-18 | | Last modified: | 2023-11-08 | | Method: | X-RAY DIFFRACTION (2.2 Å) | | Cite: | Mechanism of chiral proofreading during translation of the genetic code.
Elife, 2, 2013
|
|
3PD4
 | |
3PD3
 | |
4FD9
 | |
3PD2
 | | Crystal structure of the editing domain of threonyl-tRNA synthetase from Pyrococcus abyssi in complex with seryl-3'-aminoadenosine | | Descriptor: | SERINE-3'-AMINOADENOSINE, Threonyl-tRNA synthetase | | Authors: | Hussain, T, Kamarthapu, V, Kruparani, S.P, Sankaranarayanan, R. | | Deposit date: | 2010-10-22 | | Release date: | 2010-12-08 | | Last modified: | 2023-11-01 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | Mechanistic insights into cognate substrate discrimination during proofreading in translation
Proc.Natl.Acad.Sci.USA, 107, 2010
|
|
3PD5
 | | Crystal structure of the editing domain of threonyl-tRNA synthetase from Pyrococcus abyssi in complex with an analog of threonyl-adenylate | | Descriptor: | 5'-O-(N-(L-THREONYL)-SULFAMOYL)ADENOSINE, GLYCEROL, Threonyl-tRNA synthetase | | Authors: | Hussain, T, Kamarthapu, V, Kruparani, S.P, Sankaranarayanan, R. | | Deposit date: | 2010-10-22 | | Release date: | 2010-12-08 | | Last modified: | 2023-11-01 | | Method: | X-RAY DIFFRACTION (2.29 Å) | | Cite: | Mechanistic insights into cognate substrate discrimination during proofreading in translation
Proc.Natl.Acad.Sci.USA, 2010
|
|
3SNZ
 | |
3H2I
 | |
3H2G
 | |
3HZ2
 | |
3HZB
 | |
3H2J
 | |
3H2K
 | | Crystal structure of a ligand-bound form of the rice cell wall degrading esterase LipA from Xanthomonas oryzae | | Descriptor: | esterase, octyl beta-D-glucopyranoside | | Authors: | Aparna, G, Chatterjee, A, Sonti, R.V, Sankaranarayanan, R. | | Deposit date: | 2009-04-14 | | Release date: | 2009-08-18 | | Last modified: | 2023-11-01 | | Method: | X-RAY DIFFRACTION (2.1 Å) | | Cite: | A Cell Wall-Degrading Esterase of Xanthomonas oryzae Requires a Unique Substrate Recognition Module for Pathogenesis on Rice
Plant Cell, 21, 2009
|
|
3H2H
 | |
3IAJ
 | |
3I9H
 | |
3SNY
 | |
3SO1
 | |
3T5A
 | |
3SO0
 | |
3T5B
 | |
3T5C
 | |
8UWA
 | | VH1-18 QxxV class antibody 09-1B12 bound to A/Perth/16/2009 H3N2 hemagglutinin | | Descriptor: | 09-1B12 heavy chain, 09-1B12 light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | | Authors: | Maurer, D.P. | | Deposit date: | 2023-11-06 | | Release date: | 2024-05-08 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (4.02 Å) | | Cite: | Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Immunity, 57, 2024
|
|
8UT7
 | | CryoEM structure of A/Perth/16/2009 H3 in complex with polyclonal Fab from mice immunized with H3 stem nanoparticles-28 days post immunization | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, H3D28 pFab HC Fv_polyA, ... | | Authors: | Huang, J, Han, J, Ward, A.B. | | Deposit date: | 2023-10-30 | | Release date: | 2024-05-08 | | Last modified: | 2024-05-29 | | Method: | ELECTRON MICROSCOPY (2.7 Å) | | Cite: | Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Immunity, 57, 2024
|
|
